BioLineRx Ltd.
BLRX
$2.75
-$0.32-10.42%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.88M | 25.21M | 28.16M | 26.37M | 19.56M |
| Total Receivables | 456.00K | 699.00K | 281.00K | 1.92M | 3.86M |
| Inventory | 2.15M | 2.18M | 2.85M | 3.32M | 3.15M |
| Prepaid Expenses | 201.00K | 432.00K | 572.00K | 312.00K | 443.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 91.00K |
| Total Current Assets | 23.68M | 28.52M | 31.86M | 31.92M | 27.10M |
|
|
|||||
| Total Current Assets | 23.68M | 28.52M | 31.86M | 31.92M | 27.10M |
| Net Property, Plant & Equipment | 856.00K | 892.00K | 997.00K | 1.16M | 1.35M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 16.37M | 10.39M | 10.41M | 10.43M | 10.45M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 40.91M | 39.80M | 43.27M | 43.51M | 38.91M |
|
|
|||||
| Total Accounts Payable | 3.49M | 3.54M | 3.47M | 4.69M | 5.58M |
| Total Accrued Expenses | 1.21M | 2.13M | 2.77M | 1.75M | 3.13M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.71M | 4.78M | 4.89M | 5.12M | 5.00M |
| Total Finance Division Other Current Liabilities | 2.71M | 3.23M | 4.36M | 2.46M | 1.69M |
| Total Other Current Liabilities | 2.71M | 3.23M | 4.36M | 2.46M | 1.69M |
| Total Current Liabilities | 12.12M | 13.67M | 15.48M | 14.03M | 15.41M |
|
|
|||||
| Total Current Liabilities | 12.12M | 13.67M | 15.48M | 14.03M | 15.41M |
| Long-Term Debt | 4.46M | 5.60M | 6.72M | 7.63M | 8.96M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 977.00K | 1.00M | 998.00K | 985.00K | 1.08M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 17.56M | 20.27M | 23.20M | 22.65M | 25.45M |
|
|
|||||
| Common Stock & APIC | 401.01M | 400.69M | 399.29M | 396.20M | 391.79M |
| Retained Earnings | -401.00M | -399.62M | -398.64M | -394.70M | -399.83M |
| Treasury Stock & Other | 18.19M | 18.47M | 19.42M | 19.37M | 21.50M |
| Total Common Equity | 18.20M | 19.53M | 20.07M | 20.86M | 13.46M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.20M | 19.53M | 20.07M | 20.86M | 13.46M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 5.15M | -- | -- | -- | -- |
| Total Equity | 23.35M | 19.53M | 20.07M | 20.86M | 13.46M |
|
|
|||||